Studies genetic and neurobiological mechanisms of nicotine dependence, withdrawal, and relapse and their intersection with neurological disease. Combines behavior, electrophysiology, next-generation sequencing, and cross-species pharmacogenomics to investigate NRG3 signaling and personalized smoking-cessation strategies relevant to Alzheimer's disease risk.